ADAGRASIB

ADAGRASIB was reported 1134 times

ADAGRASIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT AIRWAY OBSTRUCTION 1 0.1667
1 NORMOCHROMIC ANAEMIA 4 0.0200
2 POLYRADICULONEUROPATHY 1 0.0192
3 FALLOPIAN TUBE OPERATION 1 0.0125
4 DYSKINESIA OESOPHAGEAL 1 0.0112
5 ADENOVIRUS TEST POSITIVE 1 0.0105
6 ENZYME INHIBITION 1 0.0104
7 BRONCHOPULMONARY DISEASE 1 0.0101
8 NEW ONSET REFRACTORY STATUS EPILEPTICUS 1 0.0091
9 AORTITIS 5 0.0073
10 PROTHROMBIN LEVEL INCREASED 2 0.0059
11 CHEST TUBE INSERTION 1 0.0053
12 PHYSICAL ABUSE 1 0.0052
13 MELANODERMA 1 0.0052
14 GRAM STAIN POSITIVE 1 0.0049
15 RASH SCARLATINIFORM 1 0.0045
16 COLORECTAL ADENOCARCINOMA 1 0.0045
17 CD4 LYMPHOCYTES INCREASED 1 0.0043
18 COLON CANCER RECURRENT 1 0.0036
19 DYSCHROMATOPSIA 3 0.0036
20 ACUTE POLYNEUROPATHY 1 0.0035
21 COLD-STIMULUS HEADACHE 1 0.0031
22 VIRAL DIARRHOEA 1 0.0029
23 PSEUDOSTROKE 1 0.0029
24 NONINFECTIVE ENCEPHALITIS 2 0.0028
25 MIXED LIVER INJURY 8 0.0027
26 LUNG ADENOCARCINOMA STAGE IV 1 0.0026
27 PALMAR ERYTHEMA 3 0.0026
28 AORTIC RUPTURE 1 0.0026
29 ADRENAL GLAND CANCER 1 0.0026
30 CLUBBING 1 0.0025
31 NON-SMALL CELL LUNG CANCER METASTATIC 2 0.0023
32 IMMUNE-MEDIATED ENCEPHALITIS 1 0.0019
33 BONE CANCER METASTATIC 1 0.0019
34 BLOOD MAGNESIUM ABNORMAL 1 0.0018
35 RADIATION NECROSIS 1 0.0017
36 HYPOCHLORAEMIA 2 0.0017
37 DERMO-HYPODERMITIS 1 0.0017
38 LYMPHATIC DISORDER 1 0.0017
39 PARACENTESIS 1 0.0016
40 SITTING DISABILITY 1 0.0016
41 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 1 0.0016
42 ABDOMINAL WALL ABSCESS 1 0.0015
43 SJS-TEN OVERLAP 1 0.0014
44 PRERENAL FAILURE 2 0.0014
45 CEREBELLAR SYNDROME 3 0.0014
46 EXPOSURE VIA BODY FLUID 1 0.0013
47 RENAL TUBULAR ATROPHY 1 0.0011
48 OOPHORECTOMY 1 0.0011
49 BRADYPNOEA 3 0.0011
50 CELL DEATH 2 0.0010
51 ONYCHALGIA 1 0.0010
52 EYE COLOUR CHANGE 1 0.0010
53 POTENTIATING DRUG INTERACTION 3 0.0009
54 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
55 NEUROLOGICAL DECOMPENSATION 2 0.0009
56 HEPATIC CYTOLYSIS 11 0.0009
57 STATUS EPILEPTICUS 9 0.0008
58 TONIC CLONIC MOVEMENTS 1 0.0008
59 HOSPITALISATION 116 0.0008
60 PHARYNGEAL ULCERATION 1 0.0008
61 NEUROMYELITIS OPTICA SPECTRUM DISORDER 1 0.0007
62 TONGUE DRY 1 0.0007
63 RESPIRATORY DEPRESSION 9 0.0007
64 JAW DISORDER 4 0.0007
65 SKIN HYPERPIGMENTATION 6 0.0007
66 PULMONARY SEPSIS 1 0.0007
67 PNEUMONIA PSEUDOMONAL 1 0.0007
68 INHIBITORY DRUG INTERACTION 1 0.0006
69 GASTROINTESTINAL TOXICITY 3 0.0006
70 VASOPLEGIA SYNDROME 1 0.0006
71 DEAFNESS BILATERAL 1 0.0006
72 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
73 KIDNEY FIBROSIS 1 0.0006
74 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
75 VOCAL CORD PARALYSIS 1 0.0006
76 VENOUS OCCLUSION 1 0.0005
77 OESOPHAGEAL SPASM 1 0.0005
78 UNRESPONSIVE TO STIMULI 14 0.0005
79 TUNNEL VISION 1 0.0005
80 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
81 GINGIVAL DISORDER 2 0.0005
82 NEOPLASM PROGRESSION 18 0.0005
83 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
84 HYPOGEUSIA 1 0.0005
85 EMPYEMA 1 0.0005
86 SUBILEUS 1 0.0005
87 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
88 ELECTROCARDIOGRAM QT PROLONGED 17 0.0005
89 BLOOD MAGNESIUM DECREASED 4 0.0005
90 RASH MACULO-PAPULAR 10 0.0004
91 MENINGITIS 3 0.0004
92 CHOLESTATIC LIVER INJURY 1 0.0004
93 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
94 DISTRIBUTIVE SHOCK 1 0.0004
95 PNEUMONITIS 12 0.0004
96 METASTASES TO MENINGES 1 0.0004
97 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
98 HAEMATOCRIT INCREASED 1 0.0004
99 RENAL FUNCTION TEST ABNORMAL 2 0.0004
100 NON-SMALL CELL LUNG CANCER 2 0.0004
101 PRODUCT PACKAGING CONFUSION 1 0.0004
102 HYPERPARATHYROIDISM SECONDARY 1 0.0004
103 ABDOMINAL INFECTION 1 0.0004
104 CANCER PAIN 1 0.0004
105 INCREASED BRONCHIAL SECRETION 1 0.0004
106 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
107 AGRANULOCYTOSIS 7 0.0004
108 HYPOCALCAEMIA 7 0.0004
109 CHEILITIS 2 0.0004
110 GASTRIC PERFORATION 1 0.0004
111 ORAL FUNGAL INFECTION 1 0.0004
112 PLEURITIC PAIN 1 0.0004
113 RASH MORBILLIFORM 1 0.0004
114 LUNG CONSOLIDATION 1 0.0004
115 DEATH 306 0.0004
116 NEUROLOGICAL SYMPTOM 2 0.0003
117 LIP PAIN 1 0.0003
118 HYPOXIA 12 0.0003
119 URINE ODOUR ABNORMAL 2 0.0003
120 METABOLIC ENCEPHALOPATHY 1 0.0003
121 CENTRAL VENOUS CATHETERISATION 1 0.0003
122 DERMATITIS ACNEIFORM 2 0.0003
123 LIVER FUNCTION TEST INCREASED 7 0.0003
124 ENCEPHALOPATHY 8 0.0003
125 DEHYDRATION 43 0.0003
126 BRAIN FOG 5 0.0003
127 RESPIRATORY RATE DECREASED 1 0.0003
128 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
129 GASTRIC ULCER 6 0.0003
130 INCOHERENT 2 0.0003
131 OEDEMA MOUTH 1 0.0003
132 PERICARDIAL EFFUSION 7 0.0003
133 NEPHRITIS 1 0.0003
134 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
135 NEOPLASM RECURRENCE 1 0.0003
136 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
137 ENCEPHALITIS 2 0.0003
138 HYPERTRANSAMINASAEMIA 2 0.0003
139 EXTRASYSTOLES 2 0.0003
140 ERYTHEMA NODOSUM 1 0.0003
141 BONE LESION 1 0.0003
142 FAECES SOFT 2 0.0003
143 AMYLASE INCREASED 1 0.0003
144 SUNBURN 2 0.0003
145 RETINOPATHY 1 0.0003
146 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
147 PRODUCT STORAGE ISSUE 1 0.0003
148 COMMUNICATION DISORDER 1 0.0003
149 DISSOCIATION 2 0.0003
150 CHOLESTASIS 5 0.0003
151 MENTAL STATUS CHANGES 7 0.0003
152 ATRIAL FLUTTER 2 0.0003
153 RENAL FAILURE 33 0.0002
154 INTERSTITIAL LUNG DISEASE 12 0.0002
155 RECURRENT CANCER 1 0.0002
156 BLOOD CREATININE INCREASED 16 0.0002
157 PHOTOSENSITIVITY REACTION 4 0.0002
158 DRUG LEVEL INCREASED 4 0.0002
159 AORTIC DISSECTION 1 0.0002
160 MUSCLE INJURY 2 0.0002
161 GASTROINTESTINAL PERFORATION 1 0.0002
162 HEMIPLEGIA 2 0.0002
163 ADVERSE EVENT 22 0.0002
164 HALLUCINATIONS, MIXED 1 0.0002
165 BRAIN OEDEMA 3 0.0002
166 ACUTE KIDNEY INJURY 36 0.0002
167 INTERVERTEBRAL DISC DISORDER 1 0.0002
168 PRODUCT DISPENSING ISSUE 1 0.0002
169 METASTATIC NEOPLASM 1 0.0002
170 BONE CANCER 1 0.0002
171 RENAL IMPAIRMENT 19 0.0002
172 PURPURA 2 0.0002
173 BLOOD CREATINE INCREASED 1 0.0002
174 ILEUS PARALYTIC 1 0.0002
175 BRAIN NEOPLASM MALIGNANT 1 0.0002
176 MENINGITIS ASEPTIC 1 0.0002
177 PNEUMONIA BACTERIAL 2 0.0002
178 HYPOMAGNESAEMIA 3 0.0002
179 PERFORMANCE STATUS DECREASED 1 0.0002
180 BLOOD SODIUM DECREASED 4 0.0002
181 HYPOVOLAEMIC SHOCK 1 0.0002
182 DECREASED APPETITE 48 0.0002
183 DIARRHOEA 133 0.0002
184 DYSSTASIA 6 0.0002
185 VITAMIN D DEFICIENCY 2 0.0002
186 PANCREATIC DISORDER 1 0.0002
187 HYPERVOLAEMIA 1 0.0002
188 HYPERNATRAEMIA 1 0.0002
189 FLUID INTAKE REDUCED 1 0.0002
190 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
191 TOXIC SKIN ERUPTION 2 0.0002
192 FEEDING DISORDER 4 0.0002
193 SKIN DISCOLOURATION 9 0.0002
194 EJECTION FRACTION DECREASED 3 0.0002
195 PERIORBITAL OEDEMA 1 0.0002
196 ASTHENIA 72 0.0002
197 VOMITING 90 0.0002
198 PARTIAL SEIZURES 1 0.0002
199 FOLLICULITIS 2 0.0002
200 FOOD CRAVING 1 0.0002
201 DYSPHAGIA 18 0.0002
202 SERUM FERRITIN INCREASED 1 0.0002
203 SUDDEN DEATH 2 0.0002
204 RETCHING 4 0.0002
205 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
206 BEHAVIOUR DISORDER 1 0.0002
207 ASTHENOPIA 1 0.0002
208 GASTROINTESTINAL PAIN 2 0.0002
209 TOOTH FRACTURE 2 0.0002
210 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
211 HEPATOTOXICITY 4 0.0002
212 INTRACRANIAL PRESSURE INCREASED 1 0.0002
213 CHOLECYSTITIS ACUTE 1 0.0002
214 BLOOD URIC ACID INCREASED 1 0.0002
215 METASTASES TO LUNG 2 0.0002
216 ELECTROLYTE IMBALANCE 2 0.0002
217 SKIN WARM 1 0.0002
218 BONE PAIN 10 0.0002
219 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
220 PLEURISY 1 0.0002
221 BLOOD POTASSIUM DECREASED 5 0.0002
222 TREATMENT NONCOMPLIANCE 9 0.0002
223 TENDON RUPTURE 2 0.0002
224 PIGMENTATION DISORDER 1 0.0002
225 PHOTOPSIA 1 0.0002
226 DRUG INTERACTION 25 0.0002
227 NODULE 2 0.0002
228 PRESCRIBED UNDERDOSE 3 0.0002
229 METASTASES TO LYMPH NODES 1 0.0001
230 OEDEMA 8 0.0001
231 GINGIVAL BLEEDING 2 0.0001
232 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
233 RESPIRATION ABNORMAL 1 0.0001
234 LYMPHOEDEMA 1 0.0001
235 HAIR GROWTH ABNORMAL 1 0.0001
236 DELIRIUM 5 0.0001
237 LARGE INTESTINE PERFORATION 1 0.0001
238 OXYGEN SATURATION DECREASED 8 0.0001
239 THERMAL BURN 1 0.0001
240 PRODUCT SUPPLY ISSUE 1 0.0001
241 METASTASIS 1 0.0001
242 HYPOPHOSPHATAEMIA 1 0.0001
243 CEREBRAL DISORDER 1 0.0001
244 TOOTH DISORDER 3 0.0001
245 PULMONARY MASS 2 0.0001
246 NAUSEA 106 0.0001
247 HEPATIC ENZYME INCREASED 9 0.0001
248 CHRONIC KIDNEY DISEASE 10 0.0001
249 HAEMODYNAMIC INSTABILITY 1 0.0001
250 LIPASE INCREASED 1 0.0001
251 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
252 PERIPHERAL SWELLING 20 0.0001
253 HYPOALBUMINAEMIA 1 0.0001
254 DRUG SCREEN POSITIVE 1 0.0001
255 NEUROPATHY PERIPHERAL 12 0.0001
256 PNEUMOTHORAX 2 0.0001
257 PRODUCTIVE COUGH 6 0.0001
258 GINGIVAL PAIN 1 0.0001
259 BLOOD PRESSURE FLUCTUATION 3 0.0001
260 BLOOD POTASSIUM INCREASED 2 0.0001
261 GASTROINTESTINAL DISORDER 11 0.0001
262 HICCUPS 1 0.0001
263 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
264 SEIZURE 14 0.0001
265 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
266 EMBOLISM 1 0.0001
267 CONFUSIONAL STATE 19 0.0001
268 HYPOPHAGIA 3 0.0001
269 FACIAL PARALYSIS 1 0.0001
270 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
271 THROMBOCYTOPENIA 13 0.0001
272 ANURIA 1 0.0001
273 STOMATITIS 7 0.0001
274 HYPOTENSION 23 0.0001
275 EOSINOPHILIA 2 0.0001
276 DRUG INTOLERANCE 11 0.0001
277 SPINAL OSTEOARTHRITIS 1 0.0001
278 PULMONARY OEDEMA 5 0.0001
279 GASTROINTESTINAL INFECTION 1 0.0001
280 GOUT 2 0.0001
281 FREQUENT BOWEL MOVEMENTS 3 0.0001
282 LIP DRY 1 0.0001
283 OPTIC NEURITIS 1 0.0001
284 BRAIN NEOPLASM 1 0.0001
285 OFF LABEL USE 95 0.0001
286 NERVE COMPRESSION 1 0.0001
287 IRON DEFICIENCY ANAEMIA 1 0.0001
288 PRODUCT DISTRIBUTION ISSUE 1 0.0001
289 PERSONALITY CHANGE 1 0.0001
290 ILLNESS 11 0.0001
291 PHOTOPHOBIA 2 0.0001
292 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
293 INTENTIONAL DOSE OMISSION 3 0.0001
294 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
295 DIZZINESS POSTURAL 1 0.0001
296 PHARYNGEAL SWELLING 1 0.0001
297 DISORIENTATION 4 0.0001
298 CONSTIPATION 22 0.0001
299 TOXICITY TO VARIOUS AGENTS 17 0.0001
300 BLADDER DISORDER 1 0.0001
301 OVARIAN CYST 1 0.0001
302 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
303 APHASIA 3 0.0001
304 PLEURAL EFFUSION 6 0.0001
305 TASTE DISORDER 2 0.0001
306 OEDEMA PERIPHERAL 12 0.0001
307 TOOTH LOSS 2 0.0001
308 VENTRICULAR EXTRASYSTOLES 1 0.0001
309 EYE DISCHARGE 1 0.0001
310 UNINTENDED PREGNANCY 1 0.0001
311 TRANSFUSION 1 0.0001
312 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
313 CYSTITIS 3 0.0001
314 BODY HEIGHT DECREASED 1 0.0001
315 WEIGHT DECREASED 26 0.0001
316 NIGHT SWEATS 3 0.0001
317 DECREASED ACTIVITY 1 0.0001
318 FAECES DISCOLOURED 2 0.0001
319 SEPTIC SHOCK 4 0.0001
320 FOOT DEFORMITY 1 0.0001
321 MALNUTRITION 1 0.0001
322 NEPHROPATHY TOXIC 1 0.0001
323 INTESTINAL PERFORATION 1 0.0001
324 ADVERSE DRUG REACTION 8 0.0001
325 FLATULENCE 5 0.0001
326 MICTURITION URGENCY 1 0.0001
327 INTERNAL HAEMORRHAGE 1 0.0001
328 ABDOMINAL PAIN UPPER 18 0.0001
329 LETHARGY 5 0.0001
330 HYPOKALAEMIA 4 0.0001
331 DRY MOUTH 7 0.0001
332 ABDOMINAL DISTENSION 9 0.0001
333 RENAL DISORDER 4 0.0001
334 SPINAL PAIN 1 0.0001
335 THERAPY INTERRUPTED 6 0.0001
336 ANAEMIA 16 0.0001
337 MYOCLONUS 1 0.0001
338 LUNG DISORDER 4 0.0001
339 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
340 SMALL INTESTINAL OBSTRUCTION 1 0.0001
341 FATIGUE 63 0.0001
342 PNEUMONIA ASPIRATION 2 0.0001
343 PRODUCT STORAGE ERROR 7 0.0001
344 DYSPNOEA EXERTIONAL 3 0.0001
345 ABDOMINAL PAIN LOWER 2 0.0001
346 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
347 INFLAMMATION 4 0.0001
348 SKIN ULCER 2 0.0001
349 DIPLOPIA 2 0.0001
350 DEAFNESS 2 0.0001
351 BEDRIDDEN 1 0.0001
352 ORAL CANDIDIASIS 1 0.0001
353 FEBRILE NEUTROPENIA 5 0.0001
354 CARDIAC DISORDER 7 0.0001
355 QUALITY OF LIFE DECREASED 1 0.0001
356 PAIN OF SKIN 2 0.0001
357 ATRIAL FIBRILLATION 7 0.0001
358 HAEMOPTYSIS 2 0.0001
359 SKIN REACTION 1 0.0001
360 LYMPHOPENIA 1 0.0001
361 DYSPNOEA 40 0.0001
362 HEPATOCELLULAR INJURY 1 0.0001
363 SINUS TACHYCARDIA 1 0.0001
364 SYNCOPE 7 0.0001
365 HYPERSOMNIA 2 0.0001
366 BACK PAIN 16 0.0001
367 RESPIRATORY FAILURE 5 0.0001
368 APATHY 1 0.0001
369 GASTROENTERITIS 1 0.0001
370 ASCITES 2 0.0001
371 LIVER DISORDER 3 0.0001
372 URINARY INCONTINENCE 2 0.0001
373 THYROID DISORDER 1 0.0001
374 MYALGIA 11 0.0001
375 ANKLE FRACTURE 1 0.0001
376 SWELLING 6 0.0001
377 THERAPY PARTIAL RESPONDER 1 0.0001
378 PRODUCT USE ISSUE 12 0.0001
379 PRODUCT USE COMPLAINT 1 0.0001
380 HEAD INJURY 2 0.0001
381 SEPSIS 7 0.0001
382 HYPOTHYROIDISM 2 0.0001
383 METABOLIC ACIDOSIS 2 0.0001
384 EYE DISORDER 2 0.0001
385 VENTRICULAR TACHYCARDIA 1 0.0001
386 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
387 NEOPLASM MALIGNANT 4 0.0001
388 BLOOD UREA INCREASED 1 0.0001
389 SOMNOLENCE 12 0.0001
390 EYE PRURITUS 2 0.0001
391 PERICARDITIS 1 0.0001
392 CANDIDA INFECTION 1 0.0001
393 HEMIPARESIS 1 0.0001
394 URINARY TRACT INFECTION 10 0.0001
395 HAEMOGLOBIN DECREASED 6 0.0001
396 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
397 MUSCULOSKELETAL DISCOMFORT 1 0.0001
398 JOINT SWELLING 7 0.0001
399 GAIT DISTURBANCE 11 0.0001
400 RASH MACULAR 2 0.0001
401 METASTASES TO LIVER 1 0.0001
402 PANCREATITIS 3 0.0001
403 BRADYCARDIA 3 0.0001
404 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
405 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
406 HEAD DISCOMFORT 1 0.0001
407 DRUG ERUPTION 1 0.0001
408 DIZZINESS 28 0.0001
409 ISCHAEMIC STROKE 1 0.0001
410 PNEUMONIA 18 0.0001
411 LEUKOCYTOSIS 1 0.0001
412 DYSURIA 2 0.0001
413 CONJUNCTIVITIS 1 0.0001
414 PANCYTOPENIA 3 0.0001
415 THINKING ABNORMAL 1 0.0001
416 HEPATIC FUNCTION ABNORMAL 2 0.0001
417 DYSARTHRIA 2 0.0001
418 INTESTINAL OBSTRUCTION 2 0.0001
419 COLITIS 2 0.0001
420 ACUTE RESPIRATORY FAILURE 1 0.0001
421 ERUCTATION 1 0.0001
422 HAEMORRHOIDS 1 0.0001
423 SURGERY 3 0.0001
424 SKIN FISSURES 1 0.0001
425 VISION BLURRED 7 0.0001
426 RASH 22 0.0001
427 SPINAL FRACTURE 1 0.0000
428 BONE MARROW FAILURE 1 0.0000
429 CARDIAC ARREST 4 0.0000
430 DERMATITIS 1 0.0000
431 HALLUCINATION, VISUAL 1 0.0000
432 OSTEOARTHRITIS 2 0.0000
433 EATING DISORDER 1 0.0000
434 LOSS OF CONSCIOUSNESS 6 0.0000
435 HYPOACUSIS 2 0.0000
436 POOR QUALITY SLEEP 1 0.0000
437 BALANCE DISORDER 4 0.0000
438 PRODUCT DISPENSING ERROR 1 0.0000
439 ORAL PAIN 1 0.0000
440 SNEEZING 1 0.0000
441 HEART RATE IRREGULAR 1 0.0000
442 CHEST PAIN 8 0.0000
443 DISEASE PROGRESSION 5 0.0000
444 PULMONARY EMBOLISM 4 0.0000
445 MOBILITY DECREASED 3 0.0000
446 BLOOD GLUCOSE DECREASED 2 0.0000
447 MENTAL IMPAIRMENT 1 0.0000
448 PRESYNCOPE 1 0.0000
449 NEURALGIA 1 0.0000
450 CEREBRAL INFARCTION 1 0.0000
451 LIVER INJURY 1 0.0000
452 DYSGEUSIA 3 0.0000
453 AGEUSIA 1 0.0000
454 DRY EYE 2 0.0000
455 LEUKOPENIA 2 0.0000
456 ACNE 3 0.0000
457 HAEMATEMESIS 1 0.0000
458 FLUID RETENTION 2 0.0000
459 HEPATITIS 1 0.0000
460 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
461 MALAISE 17 0.0000
462 RESPIRATORY TRACT INFECTION 1 0.0000
463 MUCOSAL INFLAMMATION 1 0.0000
464 SPEECH DISORDER 2 0.0000
465 HYPERTENSION 8 0.0000
466 PYREXIA 13 0.0000
467 PLATELET COUNT DECREASED 4 0.0000
468 CARDIAC FAILURE 3 0.0000
469 THROMBOSIS 3 0.0000
470 JAUNDICE 1 0.0000
471 BLOOD BILIRUBIN INCREASED 1 0.0000
472 THROAT TIGHTNESS 1 0.0000
473 RASH PRURITIC 2 0.0000
474 SKIN LESION 1 0.0000
475 MEMORY IMPAIRMENT 5 0.0000
476 ABNORMAL DREAMS 1 0.0000
477 TREMOR 6 0.0000
478 FEELING COLD 1 0.0000
479 MUSCULAR WEAKNESS 4 0.0000
480 RED BLOOD CELL COUNT DECREASED 1 0.0000
481 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
482 PAIN IN EXTREMITY 10 0.0000
483 ACUTE MYOCARDIAL INFARCTION 1 0.0000
484 LABORATORY TEST ABNORMAL 1 0.0000
485 TACHYCARDIA 3 0.0000
486 FEELING ABNORMAL 8 0.0000
487 HEPATIC FAILURE 1 0.0000
488 NASOPHARYNGITIS 6 0.0000
489 OVERDOSE 7 0.0000
490 LIMB DISCOMFORT 1 0.0000
491 VISUAL IMPAIRMENT 4 0.0000
492 DRUG-INDUCED LIVER INJURY 1 0.0000
493 ARTHRALGIA 13 0.0000
494 CONTUSION 3 0.0000
495 HYPERHIDROSIS 4 0.0000
496 DEEP VEIN THROMBOSIS 2 0.0000
497 SWELLING FACE 2 0.0000
498 DYSPEPSIA 3 0.0000
499 OSTEONECROSIS 1 0.0000
500 VISUAL ACUITY REDUCED 1 0.0000
501 VIRAL INFECTION 1 0.0000
502 URINARY RETENTION 1 0.0000
503 GAIT INABILITY 1 0.0000
504 URTICARIA 5 0.0000
505 TYPE 2 DIABETES MELLITUS 1 0.0000
506 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
507 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
508 NEUTROPENIA 4 0.0000
509 CHEST DISCOMFORT 3 0.0000
510 HAEMATURIA 1 0.0000
511 HAEMORRHAGE 3 0.0000
512 BURNING SENSATION 2 0.0000
513 HYPERKALAEMIA 1 0.0000
514 COVID-19 5 0.0000
515 LYMPHADENOPATHY 1 0.0000
516 MYELOSUPPRESSION 1 0.0000
517 ACCIDENTAL OVERDOSE 1 0.0000
518 EYE SWELLING 1 0.0000
519 CONDITION AGGRAVATED 8 0.0000
520 DIABETES MELLITUS 2 0.0000
521 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
522 PAIN 16 0.0000
523 ABDOMINAL PAIN 6 0.0000
524 CHILLS 3 0.0000
525 COUGH 7 0.0000
526 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
527 EXTRA DOSE ADMINISTERED 1 0.0000
528 NEUTROPHIL COUNT DECREASED 1 0.0000
529 OSTEOPOROSIS 1 0.0000
530 TREATMENT FAILURE 2 0.0000
531 FALL 8 0.0000
532 ABDOMINAL DISCOMFORT 4 0.0000
533 RECTAL HAEMORRHAGE 1 0.0000
534 MENTAL DISORDER 1 0.0000
535 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
536 DRY SKIN 3 0.0000
537 DEPRESSION 5 0.0000
538 TINNITUS 1 0.0000
539 BLOOD CHOLESTEROL INCREASED 1 0.0000
540 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
541 HEADACHE 13 0.0000
542 ALOPECIA 4 0.0000
543 HYPOAESTHESIA 3 0.0000
544 CELLULITIS 1 0.0000
545 THERAPY CESSATION 1 0.0000
546 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
547 INSOMNIA 5 0.0000
548 HAEMATOCHEZIA 1 0.0000
549 HYPONATRAEMIA 1 0.0000
550 EYE PAIN 1 0.0000
551 ANXIETY 5 0.0000
552 HERPES ZOSTER 1 0.0000
553 MYOCARDIAL INFARCTION 3 0.0000
554 WHEEZING 1 0.0000
555 EMOTIONAL DISTRESS 2 0.0000
556 VERTIGO 1 0.0000
557 MUSCLE SPASMS 3 0.0000
558 BLOOD GLUCOSE INCREASED 3 0.0000
559 PRURITUS 6 0.0000
560 AMNESIA 1 0.0000
561 BLOOD PRESSURE DECREASED 1 0.0000
562 INJURY 1 0.0000
563 SLEEP DISORDER 1 0.0000
564 SKIN BURNING SENSATION 1 0.0000
565 INFECTION 2 0.0000
566 AGITATION 1 0.0000
567 PRODUCT DOSE OMISSION ISSUE 4 0.0000
568 BRONCHITIS 1 0.0000
569 EPISTAXIS 1 0.0000
570 HALLUCINATION 1 0.0000
571 HOT FLUSH 1 0.0000
572 UNEVALUABLE EVENT 1 0.0000
573 PARAESTHESIA 2 0.0000
574 CARDIAC FAILURE CONGESTIVE 1 0.0000
575 DRUG INEFFECTIVE 16 0.0000
576 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
577 CEREBROVASCULAR ACCIDENT 2 0.0000
578 OROPHARYNGEAL PAIN 1 0.0000
579 BREAST CANCER 1 0.0000
580 MIGRAINE 1 0.0000
581 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
582 ERYTHEMA 2 0.0000
583 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
584 INFLUENZA 1 0.0000
585 WEIGHT INCREASED 2 0.0000
586 INCORRECT DOSE ADMINISTERED 2 0.0000
587 PALPITATIONS 1 0.0000
588 PSORIASIS 1 0.0000
589 HYPERSENSITIVITY 1 0.0000